Results 301 to 310 of about 1,384,561 (311)

Benefit‐risk assessment in pharmaceutical research and development

Pharmaceutical Statistics, 2014
openaire   +2 more sources

Quantitative benefit-risk assessment

Pharmcoepidemiology and Drug Safety, 2018
Ataher, Quazi S., Postmus, Douwe, Hillege, Hans L., Tervonen, Tommi   +3 more
openaire   +1 more source

A new proposal for benefit-less-risk analysis in clinical trials

Contemporary Clinical Trials, 1994
Christy Chuang-Stein
exaly  

Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community

Clinical Therapeutics, 2019
Rosangel Cruz, Lisa Belter, Jill Jarecki   +2 more
exaly  

Benefit-Risk Assessment in Pharmacovigilance

2018
openaire   +1 more source

Comparing diagnostic tests on benefit-risk

Journal of Biopharmaceutical Statistics, 2016
Gene Pennello, Scott R Evans
exaly  

Benefit-risk assessment of erenumab and current migraine prophylactic treatments using the likelihood of being helped or harmed

Cephalalgia, 2019
Pamela Võ, Shihua Wen
exaly  

Benefit–risk evaluation: the past, present and future

Therapeutic Advances in Drug Safety, 2019
Juhaeri Juhaeri
exaly  

Benefit–risk assessment and public communication

2014
Stephen J. Mayall, Anjan K. Banerjee
openaire   +1 more source

Benefit-Risk Assessment for Platform Trials

2018
Chunlei Ke, Qi Jiang
openaire   +1 more source